The growth in this market is driven by the growing focus on providing public-access defibrillators, rising prevalence of target diseases and training and awareness programs on defibrillators. In addition, emerging markets and the development of S-ICDs and MRI-compatible ICDs and CRT-Ds are expected to offer growth opportunities for players in the defibrillators market.
According to the research report Defibrillators Market is projected to reach $11.7 billion by 2025, growing at a CAGR of 3.4%.
Prominent players in the market include Medtronic (Ireland), St. Jude Medical (US), Boston Scientific (US), Nihon Kohden (Japan), Koninklijke Philips N.V. (Netherlands), ZOLL Medical (US), BIOTRONIK (Germany), Physio-Control (US), SCHILLER AG (Switzerland), Mindray Medical (China), Mediana (South Korea), and METsis Medikal (Turkey).
On the basis of type, the defibrillators market is segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs market is further segmented into transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is further categorized as single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds). The external market is further segmented into manual and semi-automated external defibrillators, wearable cardioverter defibrillators (WCDs) and fully automated external defibrillators.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=549